Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shin-ichi Miura

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Toxicology and Applied Pharmacology|July 1, 2005
Novel extrahepatic cytochrome P450sMaria Karlgren, Shin-ichi Miura, Magnus Ingelman-Sundberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2009
Culture period-dependent change of function and expression of ATP-binding cassette transporters in Caco-2 cellsEmi Kamiyama, Daisuke Sugiyama, Daisuke Nakai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2007
Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to allysine aldehyde in elastin of human aortaMasataka Oitate, Takashi Hirota, Takahiro Murai, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2009
CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tractKumiko Koyama, Makoto Takahashi, Masataka Oitate, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2010
Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibioticsEiko Suzuki, Naotoshi Yamamura, Yuji Ogura, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 3, 2008
Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2006
Mechanism for covalent binding of rofecoxib to elastin of rat aortaMasataka Oitate, Takashi Hirota, Makoto Takahashi, et al.
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|March 18, 2006
[Network for the collection and distribution of Japanese liver tissues resected surgically for drug development and research use]Momoko Sunouchi, Kazue Sakemi, Kei-ichi Kubota, et al.
Drug Metabolism and Pharmacokinetics|May 19, 2019
Applications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug developmentMasanobu Nishidate, Mitsuhiro Hayashi, Hiroaki Aikawa, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Toxicology and Applied Pharmacology|July 1, 2005
Novel extrahepatic cytochrome P450sMaria Karlgren, Shin-ichi Miura, Magnus Ingelman-Sundberg
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 10, 2009
Culture period-dependent change of function and expression of ATP-binding cassette transporters in Caco-2 cellsEmi Kamiyama, Daisuke Sugiyama, Daisuke Nakai, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2007
Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to allysine aldehyde in elastin of human aortaMasataka Oitate, Takashi Hirota, Takahiro Murai, et al.
Antimicrobial Agents and Chemotherapy|August 19, 2009
CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tractKumiko Koyama, Makoto Takahashi, Masataka Oitate, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 17, 2010
Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibioticsEiko Suzuki, Naotoshi Yamamura, Yuji Ogura, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 3, 2008
Mechanism-based inhibition of human cytochrome P450 2B6 by ticlopidine, clopidogrel, and the thiolactone metabolite of prasugrelYumi Nishiya, Katsunobu Hagihara, Takashi Ito, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 14, 2006
Mechanism for covalent binding of rofecoxib to elastin of rat aortaMasataka Oitate, Takashi Hirota, Makoto Takahashi, et al.
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku = Bulletin of National Institute of Health Sciences|March 18, 2006
[Network for the collection and distribution of Japanese liver tissues resected surgically for drug development and research use]Momoko Sunouchi, Kazue Sakemi, Kei-ichi Kubota, et al.
Drug Metabolism and Pharmacokinetics|May 19, 2019
Applications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug developmentMasanobu Nishidate, Mitsuhiro Hayashi, Hiroaki Aikawa, et al.
Pageof 1